Ann: Ceasing to be a substantial holder from PTM, page-36

I think it's a reality that I wasn't quite sure at that point in time, would become a necessary part of the job. Companies have an invested interest in Research and the Directors (especially people with a non-scientific background) often fail to understand or undermine the work of research. In my experience, companies that had more interest in SP and their MC, often went out of their way to produce favourable results and boasted them through announcements; were the red-flags for researchers.
The whole point of research is dependant on a very strict code-of-ethics, which can often have repercussions on the researcher's credibility. Companies that have a tendency to shower researchers with gratitude, often will go out of their way to sway researchers by buying them expensive dinners and sending them presents; it's a practice often practiced within the corporate world.
I didn't realise just how corrupted it could become. Honestly, in my case I just was not ready to be influenced by very powerful people and these companies that I worked with had very intimidating characters who often would be looking over our work (considered a violation of the code-of-ethics). Scientific research, if you would like to learn more about it, has a long history of organisations and scientists being bought to write favourable and unethical papers.
In the case of IMU, all I see is very ethical and dedicated team of professionals who'd rather wait to put out an announcement, even if it means that the holders might panic a bit. Genuine scientific data doesn't get collected over a few days or months, it can take years, and I can't even begin to imagine the effort and time that it would take for a research such as IMU has undertaken to produce definite results. I see that as a great way to run a company, from the standpoint of both being practical and ethical in staying true to their values. I believe these guys are the real-deal, they don't want to put out information too early and get the market excited.
It's one that shows they're willing to patiently wait and put out an announcement with more credible data and keeping their research team at ease. You have to understand, a combination such as the management at IMU consists of very credible researchers with a background of 10+ years within Medical Research.
Furthermore, Paul Hopper has been associated as a Biotech venture capitalist pioneer in terms of his success with working with companies and taking them to the next level. Just as an example, he played a huge role in Viralytics' success and look at where the company is now. An opportunity I definitely missed on.
If you'd like to learn more about scientific research and unethical companies, I'd recommend watching Betting on Zero; it gives a good insight into the world of medical research.
Same goes for Climate change deniers, Big Oil companies will pay whatever organisation they can to get a credible scientist to deny any claims that can hurt their company.
It's the way it is man, and unfortunately researchers can fall victim to predators.
I was lucky enough to walk away when I did, I now work in a Private consultancy, where we advise Start-up Businesses and the company's business model is to take a stake in the company we advice so often our success depends on the Start-ups success; hence obligating us to perform to the best of our abilities that the companies do well in the long-term.
Again JMHO - please DYOR. Thank you for reading my opinion.